The CeMM Proteomics and Metabolomics Facility has been designed to the highest standards with individual cubicles per machine, maintaining a constant temperature with minimal variation. State of the art resources include six liquid chromatography - mass spectrometry systems (including an Orbitrap Fusion Lumos), the infrastructure for optimally preparing proteomics and metabolomics samples for highest sensitivity detection and the computational infrastructure for comprehensive data analysis.
Established workflows enable the determination of protein-protein interactions, drug-protein interactions, quantitative expression proteomes, post-translational modifications in cell signalling pathways, and key cellular metabolites.
Head of the Proteomics and Metabolomics Facility
André C. Müller obtained his Master’s degree in biochemistry at the University of Cologne, Germany. He worked as an adjunct research associate in the Biocatalysis lab of Dr. Bettina Rosche at the School of Biotechnology and Biomolecular Sciences (BABS), University of New South Wales in Sydney, Australia before moving to Austria. André joined the mass spectrometry and proteomic research group of Dr. Keiryn Bennett in 2007 before joining the ‘Life Science and Mass Spectrometry’ based European Application Support Specialist team of Thermo Fisher Scientific. In June 2017, he returned to CeMM as head of the Proteomics and Metabolomics Facility.
Deputy Head for Metabolomics
Kristaps Klavins studied Analytical Chemistry at the University of Latvia. He undertook his graduate studies with Gunda Koellensperger at University of Natural Resources and Life Sciences, Vienna followed by an analytical scientist and senior scientist positions in R&D Department at Biocrates Life Sciences. He joined CeMM in 2017.